Market Access

Position your product in new markets with sound data and a strong reimbursement profile.

US Government Drug Reimbursement (PH204)

In the United States, attaining formulary position and negotiating prices have become increasingly complex and competitive, especially in light of new guidelines under the Affordable Care Act (ACA). Success guarantees that treatments reach patients — and that brands meet or exceed revenue expectations. This report focuses exclusively on US government reimbursement strategy and trends. This study provides actionable insights — drawn from the data and experiences of top-performing life science executives — for winning and maintaining formulary position. Data show US government reimbursement pricing systems and payer relationship management strategies.

Patient-Reported Outcomes (PH203)

Use patient-reported outcomes to guide product development and improve market access initiatives.  Leverage the healthcare consumer perspective to strengthen product value propositions during regulatory approval and reimbursement discussions and to gain insight to drive commercial potential.

Managed Markets Account Managers (PH200)

In response to payers’ increased pressure on pharmaceutical and medical device prices, the industry is leveraging new research to bolster the value proposition for new drugs and therapies. However, simply developing this information is not enough.  Managed markets teams are the effective and efficient solution to convey key data to payers.

Health Economics for Medical Devices (PH198)

Medical Device companies are increasingly under pressure to meet payer demands.  To succeed in this environment, device companies arm themselves with health economics data to satisfy payer requirements and maintain optimal price levels.

Pharmaceutical Big Data Insights (PH195)

Big Data is forcing the pharmaceutical and medical device industries to re-examine every research channel for opportunities to improve various departments’ work.  Harness Big Data to increase efficiency of data analysis during prospective and retrospective studies and better meet patient needs through improved market intelligence.

Market Access and Reimbursement (PH189)

Benchmark market access budgets and pinpoint ideal resource allocation.  Accurately measure success to prove the value of market access through tactical ROI calculations.

Health Outcomes Liaison and Managed Care Liaison Teams (PH188)

Learn strategies for building an efficient HOL team and discover best practices to get the best results out of payer interactions.

Pharmaceutical Pricing Strategy (PH185)

Build dedicated pharmaceutical pricing teams to manage a global market and increasing pharma regulations, and to embrace health economics and comparative effectiveness data.

Pharmaceutical Global Launch Sequencing (PH172)

Explore pharmaceutical launch sequencing factors, manage the impact of reference pricing and prepare for future growth in key emerging markets.

Health Economics and Outcomes Research (PH175)

Use this report to win reimbursement, align HEOR with corporate objectives, and allocate resources across health economics priorities.

U.S. Managed Markets: Driving Commercial Success through Outcomes-Based Reimbursement (PH164)

Win reimbursement, improve payer communication and build a world-class managed markets function.